DePuy Orthopaedics Newswire

DePuy Orthopaedics Newswire

Comprehensive Real-Time News Feed for DePuy Orthopaedics.

Results 1 - 20 of 1,128 in DePuy Orthopaedics

  1. Concorde Asset Management LLC Has $658,000 Position in Johnson & JohnsonRead the original story w/Photo

    15 hrs ago | Daily Political

    Concorde Asset Management LLC boosted its stake in shares of Johnson & Johnson by 42.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 5,432 shares of the company's stock after buying an additional 1,621 shares during the period.

    Comment?

  2. Cabot Wealth Management Inc. Sells 906 Shares of Johnson & JohnsonRead the original story w/Photo

    Saturday | Daily Political

    Cabot Wealth Management Inc. reduced its position in Johnson & Johnson by 1.3% during the first quarter, Holdings Channel reports. The firm owned 71,562 shares of the company's stock after selling 906 shares during the period.

    Comment?

  3. Orrstown Financial Services Inc. Sells 267 Shares of Johnson & JohnsonRead the original story w/Photo

    Saturday | Daily Political

    Orrstown Financial Services Inc. decreased its stake in Johnson & Johnson by 1.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 14,078 shares of the company's stock after selling 267 shares during the period.

    Comment?

  4. Investment Analysts' Recent Ratings Updates for Johnson & JohnsonRead the original story w/Photo

    Friday Jul 22 | AmericanBankingNews.com

    Several brokerages have updated their recommendations and price targets on shares of Johnson & Johnson in the last few weeks: 7/21/2016 - Johnson & Johnson had its price target raised by analysts at Deutsche Bank AG from $125.00 to $142.00. They now have a "hold" rating on the stock.

    Comment?

  5. Johnson & Johnson: 3 Reasons To Be Optimistic From The Q2 ResultsRead the original story w/Photo

    Friday Jul 22 | Seeking Alpha

    Johnson & Johnson reported its Q2 results on July 19th 2016, which topped analysts' estimates, leading the stock higher where it has stabilized since. We listened in on the earnings call and here are three reasons to be modestly bullish on the stock on the back of the Q2 results conference call.

    Comment?

  6. Johnson & Johnson Throws Open Its R&D Doors at Its "No Strings Attached" Incubator in San DiegoRead the original story

    Thursday Jul 21 | BioSpace

    Just five years ago, one of the last places one would have looked for innovation at Johnson & Johnson was in its Merryfield Road lab in La Jolla, Calif. The R&D facility for the healthcare giant, No.

    Comment?

  7. Paris Hilton and Ivanka Trump party at the VIP room in St.Tropez.Read the original story w/Photo

    Thursday Jul 21 | The Daily Beast

    In the early-to-mid aughts, Donald Trump's favorite child was palling around with Paris Hilton and starred in the nauseating documentary Born Rich , about spoiled heirs and heiresses. The 2003 documentary was the brainchild of Jamie Johnson, the 23-year-old Johnson & Johnson heir.

    Comment?

  8. Antibodies Market: North Americaa s Revenue Share to Reach 44% in 2016Read the original story w/Photo

    Thursday Jul 21 | Freshnews

    High rate of product approvals, combined with rising adoption of therapeutic antibodies ] in developing economies is positively influencing the growth of the global antibodies market, with total revenues expected to surpass US$ 105 Bn in 2016. Approval of monoclonal antibody products, including therapeutic antibodies, drug conjugates, and antibody fragments in key markets of the U.S., Europe, and Japan have bolstered the growth of the global antibodies market.

    Comment?

  9. Johnson & Johnson (JNJ) Issues Earnings Results, Beats Expectations By $0.06 EPSRead the original story w/Photo

    Wednesday Jul 20 | Daily Political

    Johnson & Johnson announced its quarterly earnings results on Tuesday. The company reported $1.74 EPS for the quarter, topping analysts' consensus estimates of $1.68 by $0.06.

    Comment?

  10. Contact Lens Market 2016 Global Trends, Market Share, Industry Size,...Read the original story

    Wednesday Jul 20 | World News Report

    PUNE, INDIA, July 20, 2016 / EINPresswire.com / -- About the Contact Lens Market Contact lenses are a replacement for corrective glasses due to their better aesthetic and cosmetic appeal. They are thin lenses that are placed directly on the surface of the eye and are worn to correct vision or for other therapeutic purposes.

    Comment?

  11. SmarTrend Morning Call for July 20, 2016Read the original story w/Photo

    Wednesday Jul 20 | Minyanville

    This article is published in collaboration with Scutify , where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App , the Scutify Android App or visit Scutify.com.

    Comment?

  12. Johnson & Johnson (JNJ) Given New $113.00 Price Target at Jefferies GroupRead the original story w/Photo

    Wednesday Jul 20 | Daily Political

    The firm currently has a hold rating on the stock. A number of other research analysts also recently commented on the stock.

    Comment?

  13. S&P pulls back from recordRead the original story w/Photo

    Wednesday Jul 20 | Iol.co.za

    The S&P 500 pulled back from record highs on Tuesday, while the Dow industrials edged up for an eighth straight day of gains, as investors digested mixed earnings reports amid lowered expectations for global economic growth. Netflix's disappointing quarterly results weighed on the S&P 500 and the Nasdaq, while Johnson & Johnson's strong earnings and forecast helped prop up the Dow.

    Comment?

  14. Economic Recovery? Stocks Say NoRead the original story w/Photo

    Wednesday Jul 20 | Bloomberg

    Christopher Langner is a markets columnist for Bloomberg Gadfly. He previously covered corporate finance for Bloomberg News, and has written for Reuters/IFR, Forbes, the Wall Street Journal and Mergermarket.

    Comment?

  15. Johnson & Johnson (JNJ) Stake Reduced by guardian investment managementRead the original story w/Photo

    Tuesday Jul 19 | Daily Political

    The firm owned 33,568 shares of the company's stock after selling 2,632 shares during the period. Johnson & Johnson makes up 4.2% of guardian investment management's portfolio, making the stock its 6th largest position.

    Comment?

  16. Nikko Asset Management Americas Inc. Sells 1,900 Shares of Johnson & JohnsonRead the original story w/Photo

    Tuesday Jul 19 | Daily Political

    Nikko Asset Management Americas Inc. lowered its stake in Johnson & Johnson by 12.1% during the second quarter, Holdings Channel reports. The firm owned 13,800 shares of the company's stock after selling 1,900 shares during the period.

    Comment?

  17. US close: Stocks mixed after raft of corporate earningsRead the original story w/Photo

    Tuesday Jul 19 | Live Charts

    US stocks finished mixed on Tuesday as investors waded through a batch of corporate earnings from the likes of Johnson & Johnson and Lockheed Martin. The Dow Jones Industrial rose 0.14% but US stocks wavered on Tuesday as investors weighed corporate earnings from the likes to Goldman Sachs, Netflix and Yahoo.

    Comment?

  18. Johnson & Johnson Boosts Dow, Netflix Pressures the S&P 500Read the original story w/Photo

    Tuesday Jul 19 | TheStreet.com

    While better-than-expected earnings from Johnson & Johnson pushed the Dow Jones Industrial Average to close out the day with another record, disappointment over Netflix pushed the S&P 500 and Nasdaq into the red. The S&P 500 was down 0.14%, and the Nasdaq slid 0.4%.

    Comment?

  19. Johnson & Johnson (JNJ) Alex Gorsky on Q2 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    Tuesday Jul 19 | Seeking Alpha

    Good morning, and welcome to Johnson & Johnson's second quarter 2016 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference.

    Comment?

  20. Johnson & Johnson Hits Record High Despite Declines in Baby CareRead the original story w/Photo

    Tuesday Jul 19 | TheStreet.com

    Shares in the pharmaceutical company, which has a market cap of $343.7 billion, hit $127, an all time high, in pre-opening trading Tuesday, after its reported earnings per share of $1.74 beat Wall Street's consensus estimate by six cents. The stock fell back to $124.93 by midday, though it was still up approximately 1% from the market's open.

    Comment?